[1]Peng JJ，Zhu J，Liu FQ，et al.Expert consensus on diagnosis and treatment of locally advanced rectal cancer［J］.Journal of Chinese Cancer，2017，27(1)：41-80.［彭俊杰，朱骥，刘方奇，等.中国局部进展期直肠癌诊疗专家共识J］.中国癌症杂志，2017，27(1)：41-80.］
[2]Crawford J，Becker PS，Armitage JO，et al.Myeloid growth factors，version 2.2017，NCCN clinical practice guidelines in oncology［J］.Journal of the National Comprehensive Cancer Network J，2017，15(12)：1520.
[3]Pettersson D，Lrinc E，Holm T，et al.Tumour regression in the randomized Stockholm Ⅲ trial of radiotherapy regimens for rectal cancer［J］.British Journal of Surgery，2015，102(8)：972-978.
[4]Ngan SY，Burmeister B，Fisher RJ，et al.Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer：Trans-Tasman Radiation Oncology Group trial 01.04［J］.J Clin Oncol，2012，30(31)：3827.
[5]Bujko K，Nowacki MP，Nasierowska-Guttmejer A，et al.Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer［J］?British Journal of Surgery，2006，93(10)：1215-1223.
[6]Lu Zhao，Cheng Pu，Su Hao，et al.Prognostic analysis of pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer［J］.Modern Oncology，2018，26(05)：718-722.［卢召，程璞，苏昊，等.局部晚期直肠癌新辅助治疗后病理完全缓解者的预后分析［J］.现代肿瘤医学，2018，26(05)：718-722.］
[7]Probst CP，Becerra AZ，Aquina CT，et al.Extended intervals after neoadjuvant therapy in locally advanced rectal cancer：The key to improved tumor response and potential organ preservation［J］.Journal of the American College of Surgeons，2015，221(2)：430-440.
[8]Rombouts AJ，Hugen N，Elferink MA，et al.Treatment interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients：A population-based study［J］.Annals of Surgical Oncology，2016，23(11)：1-9.
[9]Kittinut Timudom,Natthawut Phothong,Thawatchai Akaraviputh,et al.Does extending the waiting time of low-rectal cancer surgery after neoadjuvant chemoradiation increase the perioperative complications［J］?Gastroenterology Research and Practice，2016，2016(8)：1-5.
[10]Petrelli F，Sgroi G，Sarti E，et al.Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer：A Meta-analysis of published studies［J］.Annals of Surgery，2016，263(3)：458.
[11]Lefevre JH，Mineur L，Kotti S，et al.Effect of interval（7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer：A multicenter，randomized，controlled trial（GRECCAR-6)［J］.J Clin Oncol，2016，34(31)：3773.
[12]Pettersson D，Cedermark B，Holm T，et al.Interim analysis of the Stockholm Ⅲ trial of preoperative radiotherapy regimens for rectal cancer［J］.British Journal of Surgery，2010，97(4)：580-587.
[13]Pettersson D，Holm T，Iversen H，et al.Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer［J］.British Journal of Surgery，2012，99(4)：577-583.
[14]Pach R，Kulig J，Richter P，et al.Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer-treatment results at 5-year follow-up［J］.Langenbecks Archives of Surgery，2012，397(5)：801-807.
[15]Bosset JF，Calais G，Mineur L，et al.Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer：Long-term results of the EORTC 22921 randomised study［J］.Lancet Oncology，2014，15(2)：184-190.
[16]Glynne-Jones R，Meadows H，Wood W.Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer：CHRONICLE.A randomised phase Ⅲ trial of control vs capecitabine plus oxaliplatin［J］.Clinical Oncology，2007，19(5)：327.
[17]Garciaaguilar J，Chow OS，Smith DD，et al.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer：A multicentre，phase Ⅱ trial［J］.Lancet Oncology，2015，16(8)：957-966.
[18]Huang CM，Huang MY，Hsiang-Lin T，et al.An observational study of extending FOLFOX chemotherapy，lengthening the interval between radiotherapy and surgery，and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy［J］.Therapeutic Advances in Gastroenterology，2016，9(5)：702-712.
[19]Bujko K，Wyrwicz L，Rutkowski A，et al.Long-course oxaliplatin-based preoperative chemoradiation versus 5×5 Gy and consolidation chemotherapy for cT4 or fixed，cT3 rectal cancer：Results of a randomized phase Ⅲ study［J］.Annals of Oncology，2016，27(5)：834.
[20]Myerson RJ，Tan B，Hunt S，et al.Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer［J］.Int J Radiat Oncol Biol Phys，2014，88(4)：829-836.
[21]Nilsson PJ，Van EB，Hospers GA，et al.Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer-the RAPIDO trial［J］.BMC Cancer，2013，13(1)：1-9.
[22]Huang M，Lin J，Yu X，et al.Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone：A randomized trial report［J］.International Journal of Colorectal Disease，2016，31(7)：1349-1357.
[23]Luo Lidan，Chen Haibing，Xu Jinyong，et al.Effect of neoadjuvant chemo-radiotherapy on defecation function of locally advanced rectal cancer after sphincter preserving［J］.Modern Oncology，2018，26（08)：1232-1236.［罗丽丹，陈海冰，许进勇，等.新辅助放化疗对局部进展期直肠癌保肛术后排便功能的影响［J］.现代肿瘤医学，2018，26(08)：1232-1236.］
[24]Swellengrebel HA，Marijnen CA，Verwaal VJ，et al.Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer［J］.British Journal of Surgery，2011，98(3)：418-426.
[25]Kalyan A，Rozelle S，Benson A.Neoadjuvant treatment of rectal cancer：Where are we now［J］?Gastroenterology Report，2016，4(3)：206-209.
[26]Schrag D，Weiser MR，Goodman KA，et al.Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer：A pilot trial［J］.J Clin Oncol，2014，32(6)：513.
[27]Weiser MR，Fichera A，Schrag D，et al.Progress in the PROSPECT trial：Precision treatment for rectal cancer［J］?Bull Am Coll Surg，2015，100(4)：51-52.